Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Estradiol valerate 2mg tablets
0604011K0AAABAB
|
Estradiol valerate | Estradiol valerate | Endocrine System | 10,273 |
|
Progynova 2mg tablets
0604011K0BBABAB
|
Progynova (Tablet) | Estradiol valerate | Endocrine System | 10,061 |
|
Progynova 1mg tablets
0604011K0BBAAAA
|
Progynova (Tablet) | Estradiol valerate | Endocrine System | 7,725 |
|
Estradiol valerate 1mg tablets
0604011K0AAAAAA
|
Estradiol valerate | Estradiol valerate | Endocrine System | 7,620 |
|
Climaval 1mg tablets
0604011K0BCAAAA
|
Climaval | Estradiol valerate | Endocrine System | 1 |
|
Climaval 2mg tablets
0604011K0BCABAB
|
Climaval | Estradiol valerate | Endocrine System | No data available |
|
FemTab 1mg tablets
0604011K0BEAAAA
|
FemTab | Estradiol valerate | Endocrine System | No data available |
|
FemTab 2mg tablets
0604011K0BEABAB
|
FemTab | Estradiol valerate | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.